SEC Form 4 · accession 0001209191-17-064399
Foundation Medicine, Inc. · FMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason Ryan
Officer — Chief Financial Officer
Period of report
Dec 5, 2017
Accepted (ET)
Dec 7, 2017 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001488613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 5, 2017 | M | 3,038 | $0.08 | A | 55,639 | D | |
| Common StockF1 | Dec 5, 2017 | S | 3,038 | $61.26 | D | 52,601 | D | |
| Common Stock | Dec 5, 2017 | M | 18,688 | $7.12 | A | 71,289 | D | |
| Common StockF1 | Dec 5, 2017 | S | 18,688 | $61.26 | D | 52,601 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| stock option (right to buy)F2 | $0.08 | Dec 5, 2017 | M | 3,038 | D | — | Jun 15, 2021 | Common Stock | 3,038 | 0 | D |
| stock option (right to buy)F3 | $7.12 | Dec 5, 2017 | M | 18,688 | D | — | May 21, 2023 | Common Stock | 18,688 | 1,562 | D |
Explanation of responses
- F1The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.35 to $62.85, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
- F2This option was granted on June 15, 2011. Twenty-five percent vested on May 16, 2012 and an additional 6.25% vested in equal quarterly installments until fully vested on May 16, 2015.
- F3This option was granted on May 21, 2013 and vests in equal quarterly installments beginning on April 1, 2014 until fully vested on January 1, 2018.